312
K. Fujimoto et al.
a-helical structures are regarded as powerful candidates for the aforementioned
purpose because a-helices are of key importance in protein interactions.
Recently, we succeeded in stabilization of the helices of short peptides by
bridging their amino acid side chains with cross-linking agents [1, 2].1 DNA-
binding cross-linked peptides were first designed and synthesized on the basis of the
binding sites for protein–DNA interactions, and the peptides were then labeled at
their N-termini with Tokyo green [6] to evaluate the binding efficiency of the
peptides to DNAs [7]. The fluorescent, cross-linked peptides retained stable helical
structures and had high binding affinity with substrate specificity for DNAs. The
cross-linked peptides were found to be more stable for protease than non-cross-
linked peptides, and their molecular weights were approximately 3,000. From
different perspectives, fluorescent helical peptides have potential use as specific
probes for specific proteins of clinical importance. Therefore, taking into account
our previous findings, we prepared fluorescent, cross-linked peptides by using a
variety of fluorophores and revealed their high helix content by CD analysis.
Experimental
Synthesis of 3-[4-(7-hydroxycoumarin-3-ylethynyl)phenyl]propanoic acid
To a THF (6 mL) solution of 3-bromo-7-hydroxycoumarin (120 mg, 0.5 mmol),
Pd(PPh3)4 (29 mg, 0.025 mmol), and CuI (9.5 mg, 0.05 mmol,) at 70 °C under an
Ar atmosphere, was added a solution of 3-(4-ethynylphenyl)propanoic acid [8]
(120 mg, 0.85 mmol) in Et3N (10 mL). The reaction mixture was heated under
reflux for 6 h. After removal of the solvent by use of a rotary evaporator, the residue
was dissolved in aqueous 1 M HCl and extracted with AcOEt. The AcOEt extract
was evaporated by use of a rotary evaporator and chromatographed (silica gel;
mobile phase from CH2Cl2 to CH2Cl2–CH3OH 10:1 v/v) to give 3-[4-(7-
hydroxycoumarin-3-ylethynyl)phenyl]propanoic acid: yield 57 % (95 mg); mp
231–233 °C; IR (KBr) v = 3384, 1705, 1610, 1567, 1502, 1302, 1225, 1150,
1120 cm-1 1H NMR (DMSO-d6) d = 2.57 (t, J = 7.6 Hz, 2 H), 2.86 (t, J =
;
7.6 Hz), 6.76 (d, J = 2.0 Hz, 1 H), 6.84 (dd, J = 2.4, 8.8 Hz, 1 H), 7.20 (d, J =
8.0 Hz, 2 H), 7.44 (d, J = 8.0 Hz, 2 H), 7.57 (d, J = 8.4 Hz, 1 H), 8.29 (s, 1 H),
10.83 (s, 1 H), 12.17 (s, 1 H); 13C NMR (DMSO-d6) d = 30.1, 34.6, 84.0, 93.0,
102.1, 106.3, 111.2, 113.7, 119.4, 128.7, 129.9, 131.2, 142.2, 146.4, 154.9, 159.0,
162.1, 173.5; HRMS (ESI): m/z: calcd for C20H14NaO5 [M?Na]? 357.0739; found
357.0732.
Synthesis of fluorescent, cross-linked peptides
The extending reaction of amino acid residues were performed with an automated
peptide synthesizer on an Fmoc-NH-SAL resin (capacity 0.59 mmol/g). After the
automated synthesis, the N-terminal amino groups of the peptides were
1
Other helical peptides and helical mimetics are discussed in Refs. [3–5].
123